000131297 001__ 131297
000131297 005__ 20240208113737.0
000131297 0247_ $$2doi$$a10.1177/0964528420947426
000131297 0248_ $$2sideral$$a120020
000131297 037__ $$aART-2020-120020
000131297 041__ $$aeng
000131297 100__ $$aCuenca Zaldívar, JN
000131297 245__ $$aEffectiveness of dry needling for upper extremity spasticity, quality of life and function in subacute phase stroke patients
000131297 260__ $$c2020
000131297 5060_ $$aAccess copy available to the general public$$fUnrestricted
000131297 5203_ $$aBackground: Stroke is the fourth leading cause of death in Europe, represents one of the most common causes of disability in adult patients, and involves considerable short- and long-term social and healthcare costs. The effectiveness of deep dry needling (DDN) on affected arm functionality was assessed throughout 8¿weeks of treatment in patients with stroke in the subacute phase.
Methods: Eighty patients were included in this two-group non-randomised study after a propensity score analysis was carried out. Both groups received standard physiotherapy treatment on the affected arm. The needling group also received six sessions of DDN during the 8-week period. Patients were evaluated before and after each session using the Fugl-Meyer upper extremity (FM UE) scale, the modified modified Ashworth scale (MMAS), the resistance to passive movement scale (REPAS) and a 10-point numeric pain rating scale (NPRS 10). The Brunnstrom recovery stage was recorded at the beginning and at the end of the study, and the EuroQoL quality of life survey was completed at the beginning of the study, after the first month of treatment and at the end of the study.
Results: Patients treated with DDN showed a reduction in spasticity measured using the REPAS (p¿<¿0.001) and the MMAS (p¿<¿0.05). There was also an improvement in the Brunnstrom recovery stages (p¿<¿0.05).
Conclusion: The addition of a specific DDN treatment to a standard physiotherapy treatment appeared to lead to a higher reduction in spasticity in the affected arm; however, it did not provide additional changes in functionality, pain and quality of life. Further studies with a randomised controlled trial design are required to confirm our findings.
000131297 540__ $$9info:eu-repo/semantics/openAccess$$aAll rights reserved$$uhttp://www.europeana.eu/rights/rr-f/
000131297 590__ $$a2.267$$b2020
000131297 591__ $$aINTEGRATIVE & COMPLEMENTARY MEDICINE$$b17 / 28 = 0.607$$c2020$$dQ3$$eT2
000131297 592__ $$a0.62$$b2020
000131297 593__ $$aComplementary and Alternative Medicine$$c2020$$dQ1
000131297 593__ $$aNeurology (clinical)$$c2020$$dQ1
000131297 593__ $$aMedicine (miscellaneous)$$c2020$$dQ1
000131297 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/acceptedVersion
000131297 700__ $$0(orcid)0000-0002-1674-7788$$aCalvo, S
000131297 700__ $$aBravo-Esteban, E
000131297 700__ $$aOliva Ruiz, P
000131297 700__ $$aSanti-Cano, MJ
000131297 700__ $$0(orcid)0000-0002-9201-0120$$aHerrero, Pablo$$uUniversidad de Zaragoza
000131297 7102_ $$11006$$2413$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Fisioterapia
000131297 773__ $$g39, 4 (2020), 299-308$$pACUPUNCTURE IN MEDICINE$$tAcupuncture in Medicine$$x0964-5284
000131297 8564_ $$s263585$$uhttps://zaguan.unizar.es/record/131297/files/texto_completo.pdf$$yPostprint
000131297 8564_ $$s1188876$$uhttps://zaguan.unizar.es/record/131297/files/texto_completo.jpg?subformat=icon$$xicon$$yPostprint
000131297 909CO $$ooai:zaguan.unizar.es:131297$$particulos$$pdriver
000131297 951__ $$a2024-02-08-10:52:52
000131297 980__ $$aARTICLE